Abstract
Characteristics of patients (pts) with muscle-invasive urothelial carcinoma (MIUC) who received adjuvant nivolumab (NIVO) or adjuvant platinum-based chemotherapy (CHEMO) in the real-world (RW) setting.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have